Kangchen Pharmaceuticals Co., Ltd. (603590.SH) plans to launch a restricted stock incentive plan for 2026.

Zhixin Finance and Economics APP News, Kangchen Pharmaceutical (603590.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft), proposing to grant 2.455 million restricted stocks to the incentive objects, accounting for 1.54% of the total share capital of the company at the time of the announcement of the incentive plan draft. Among them, 2.275 million shares will be granted for the first time, with 180,000 shares reserved for future grants. The total number of incentive objects to be initially granted is 63. The grant price for the restricted stocks (including reserved) is 15.75 yuan per share.